
    
      Patients will be randomized using sealed and numbered envelopes and will be assigned to
      receive a similar ovarian stimulation regime incorporating either Gonal-F or highly purified
      Fostimon as the hormonal analog. Ovarian response using either of the two compounds,
      pregnancy rates and miscarriage rates will be compared to define possible statistical
      significance.
    
  